Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Recurrent UTIsCatheter-Related Infections
Interventions
DRUG

Nissle 1917

Uropathogens will be challenged to share the same in vitro environment with Nissle 1917.

Trial Locations (1)

43206

Nationwide Children's Hospital, Columbus

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

Nationwide Children's Hospital

OTHER

NCT01696227 - Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children | Biotech Hunter | Biotech Hunter